ACE Inhibitors News and Research

RSS
ACE inhibitors act to reduce hypertension by interfering with the conversion of angiotensin I to artery-constricting angiotensin II. Blocking the production of angiotensin II results in arterial vasodilation and an accompanying reduction in blood pressure. ACE inhibitors currently are recommended as first-line therapy for hypertension in certain patient populations, because of their safety and efficacy.
ACE inhibitors should not be discontinued over fears about COVID-19, say researchers

ACE inhibitors should not be discontinued over fears about COVID-19, say researchers

High blood pressure drugs found to be safe for COVID-19 patients

High blood pressure drugs found to be safe for COVID-19 patients

New clinical trial to assess whether hypertension drug may reduce COVID-19 severity

New clinical trial to assess whether hypertension drug may reduce COVID-19 severity

Radboudumc researchers find essential mechanism in the disease process of COVID-19

Radboudumc researchers find essential mechanism in the disease process of COVID-19

ACE inhibitors appear to be safe and beneficial for COVID-19, say researchers

ACE inhibitors appear to be safe and beneficial for COVID-19, say researchers

Study shows why people with certain heart diseases may be more susceptible to COVID-19

Study shows why people with certain heart diseases may be more susceptible to COVID-19

RAS inhibitors and COVID-19 severity in hypertensive patients

RAS inhibitors and COVID-19 severity in hypertensive patients

Meis1 protein plays key role in stopping cell division in the heart

Meis1 protein plays key role in stopping cell division in the heart

Research offers clues to how SARS-CoV-2 gets into respiratory tissue and exploits our defenses

Research offers clues to how SARS-CoV-2 gets into respiratory tissue and exploits our defenses

Role of ACE/ARB inhibitors in the treatment of COVID-19

Role of ACE/ARB inhibitors in the treatment of COVID-19

Do ACE inhibitors increase SARS-CoV-2 binding to ACE2?

Do ACE inhibitors increase SARS-CoV-2 binding to ACE2?

Trial to evaluate how blood pressure medications affect outcomes among COVID-19 patients

Trial to evaluate how blood pressure medications affect outcomes among COVID-19 patients

Hypertensive patients on ACE inhibitors and angiotensin receptor blockers may have improved COVID-19 prognosis

Hypertensive patients on ACE inhibitors and angiotensin receptor blockers may have improved COVID-19 prognosis

COVID-19 adversely impacts patients with cardiovascular disease and metabolic disorders

COVID-19 adversely impacts patients with cardiovascular disease and metabolic disorders

Antihypertensive drugs may protect against COVID-19 in heart patients

Antihypertensive drugs may protect against COVID-19 in heart patients

Higher serum EPA levels from prescription fish oil associated with lower cardiovascular events

Higher serum EPA levels from prescription fish oil associated with lower cardiovascular events

COVID-19 and its effects on the cardiovascular system

COVID-19 and its effects on the cardiovascular system

Heart and kidney patients should keep taking their medicines during COVID-19 pandemic

Heart and kidney patients should keep taking their medicines during COVID-19 pandemic

What happens when COVID-19 and cardiovascular diseases mix?

What happens when COVID-19 and cardiovascular diseases mix?

Patients treated with ACEIs and ARBs may be at increased risk of severe COVID-19

Patients treated with ACEIs and ARBs may be at increased risk of severe COVID-19